These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6448870)

  • 1. Plant-Derived Compounds and Extracts as Modulators of Plasmin Activity-A Review.
    Kolodziejczyk-Czepas J; Czepas J
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic States.
    Moore HB
    Semin Thromb Hemost; 2023 Jul; 49(5):433-443. PubMed ID: 36318960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmin inhibition by bacterial serpin: Implications in gum disease.
    Sochaj-Gregorczyk A; Ksiazek M; Waligorska I; Straczek A; Benedyk M; Mizgalska D; Thøgersen IB; Enghild JJ; Potempa J
    FASEB J; 2020 Jan; 34(1):619-630. PubMed ID: 31914706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.
    Zhou HM; Nichols A; Meda P; Vassalli JD
    EMBO J; 2000 Sep; 19(17):4817-26. PubMed ID: 10970872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pepsin fibrinolysis of artificial clots made from fibrinogen concentrate and bovine thrombin: the effect of pH and epsilon aminocaproic acid.
    Valenzuela GA; Spotnitz WD; Stone DD
    Surg Endosc; 1989; 3(3):148-51. PubMed ID: 2510330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural inhibitors of fibrinolysis.
    Collen D
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():24-30. PubMed ID: 6448870
    [No Abstract]   [Full Text] [Related]  

  • 7. The fibrinolytic system and its relation to inflammatory diseases.
    Clemmensen I; Andersen RB
    Semin Arthritis Rheum; 1982 May; 11(4):390-8. PubMed ID: 6179164
    [No Abstract]   [Full Text] [Related]  

  • 8. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of plasminogen activators and inhibitors with plasminogen and fibrin.
    Lijnen HR; Collen D
    Semin Thromb Hemost; 1982 Jan; 8(1):2-10. PubMed ID: 6460318
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood coagulation mechanism from the viewpoint of molecular biochemistry: Mechanism of fibrinolysis].
    Matsuda T
    Rinsho Byori; 1985 Sep; 33(9):982-8. PubMed ID: 2416968
    [No Abstract]   [Full Text] [Related]  

  • 11. [Natural inhibitors of fibrinolysis and their physiological importance].
    Pastorova VE
    Usp Fiziol Nauk; 1974; 5(4):80-95. PubMed ID: 4279526
    [No Abstract]   [Full Text] [Related]  

  • 12. The lysis of artificially induced intravascular clots in man by intravenous infusions of streptokinase.
    JOHNSON AJ; McCARTY WR
    J Clin Invest; 1959 Sep; 38(9):1627-43. PubMed ID: 14407413
    [No Abstract]   [Full Text] [Related]  

  • 13. THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION.
    FLETCHER AP; ALKJAERSIG N; SHERRY S; GENTON E; HIRSH J; BACHMANN F
    J Lab Clin Med; 1965 May; 65():713-31. PubMed ID: 14281368
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.